Aprea aprea.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Aprea is a biotech company focusing on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53. The Company's lead program, APR-246, is a first-in-class small molecule drug candidate in clinical development.

Aprea is a biotech company focusing on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53. The Company's lead program, APR-246, is a first-in-class small molecule drug candidate in clinical devel...Show all

Company (Alive / Active)

Phone: +46 (0)8-50884504

Fax:

Karolinska Institutet Science Park
Nobels väg 3
Solna, 171 65
Sweden

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Aprea $50.4M Mar 9, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Aprea Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
HealthCap Venture CapitalVenture CapitalLausanne, SwitzerlandSeries B
5AM VenturesVenture CapitalMenlo Park, California, United StatesSeries B
Rosetta CapitalPrivate EquityPittsburgh, Pennsylvania, United States
Karolinska DevelopmentAsset/Investment ManagementSolna, SwedenOther Investors
Rosetta CapitalVenture CapitalLetchworth Garden City, England, United KingdomOther Investors
See all 7 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.